Topic Editors





New Research on Atrial Fibrillation
Topic Information
Dear Colleagues,
Atrial fibrillation is the most common sustained arrhythmia in adults, with an estimated prevalence ranging between 2% and 4%. Atrial fibrillation is responsible for 20%–30% of all ischemic strokes and significantly increases the risk of heart failure, dementia and chronic kidney disease. Moreover, atrial fibrillation has a significant impact on quality of life and functional status, especially in patients with a high burden of cardiovascular comorbidities.
Atrial fibrillation poses a considerable burden for healthcare systems, requiring a multidisciplinary approach for early detection, effective pharmacological and/or interventional treatments, and complication prevention.
In recent years, multiple efforts have been devoted to obtaining an effective rhythm control strategy and stroke prophylaxis. Transcatheter ablation has become the most effective arrhythmia control strategy currently available. Specifically, the adoption of novel nonthermal energy sources for cardiac tissue ablation has substantially improved the safety and efficacy of this approach. Similarly, new devices with which to exclude the left atrial appendage from systemic circulation have proven noninferior in preventing thromboembolic events compared to oral anticoagulation in high-risk patients. Researchers in this field are encouraged to submit an original research or review article to this Topic that can provide useful insights into the clinical updates and perspectives directed to the management of atrial fibrillation, with a particular emphasis on catheter ablation and stroke prophylaxis.
Dr. Michele Magnocavallo
Dr. Domenico G. Della Rocca
Dr. Stefano Bianchi
Dr. Pietro Rossi
Dr. Antonio Bisignani
Topic Editors
Keywords
- atrial fibrillation
- catheter ablation
- stroke prevention
- dementia
- left atrial appendage closure
- chronic kidney disease
- heart failure
- direct oral anticoagulant
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
---|---|---|---|---|---|---|
![]()
Diagnostics
|
3.0 | 4.7 | 2011 | 20.3 Days | CHF 2600 | Submit |
![]()
Geriatrics
|
2.1 | 3.3 | 2016 | 23.9 Days | CHF 1800 | Submit |
![]()
Journal of Cardiovascular Development and Disease
|
2.4 | 2.6 | 2014 | 25.7 Days | CHF 2700 | Submit |
![]()
Medicina
|
2.4 | 3.3 | 1920 | 17.1 Days | CHF 2200 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.